Stock 301093 JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

Equities

301093

CNE100004YH2

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
23.26 CNY -0.60% Intraday chart for Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. +2.92% -27.99%
Apr. 25 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 21 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback announced on June 6, 2023 has closed with 6,412,625 shares, representing 4.81% for CNY 199.59 million.
CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 6, 2023.
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 26, 2023.
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves Cash Dividend for the Year 2022
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Proposes Final Cash Dividend for 2022
CI
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Chongqing Fuling Sanhai Lanling Co., Ltd. announced that it expects to receive CNY 576.3965 million in funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 07 June 2022
CI
Jiangsu Hualan New Pharmaceutical Material Co., Ltd. Approves Cash Dividend for 2021
CI
Jiangsu Hualan New Pharma to List 1.8 Million Shares Post IPO Lock-Up Period
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301093 Stock
  4. News Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW